Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Technology in Cancer Research and Treatment is Scopus-indexed (Q2, CiteScore 5.2), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1533-0338Verify ISSN ↗1533-0346Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 146 / 428 | 66th | Q2 |
| Cancer Research | 121 / 233 | 48th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q2, CiteScore 5.2.
Technology in Cancer Research and Treatment is Q2 in Oncology (rank 146 of 428) and Q3 in Cancer Research (rank 121 of 233), by CiteScore 2025.
Technology in Cancer Research and Treatment is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.2, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.674, quartile Q2, with an H-index of 78.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Technology in Cancer Research and Treatment is published by SAGE Publications Inc. Its print ISSN is 1533-0338 and its online ISSN is 1533-0346.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Technology in Cancer Research and Treatment has an h-index of 87 and a 2-year mean of 3.09 citations per paper (OpenAlex). Its Scopus CiteScore is 5.2, quartile Q2. On 2-year citations it ranks #105 of 424 Scopus journals in Oncology.
Technology in Cancer Research and Treatment published 163 papers in 2025; its busiest recent year was 2020 with 320. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (69.3%), United States (12.6%) and Türkiye (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 115 retracted papers are recorded (36.1 per 1,000 papers). The Problematic Paper Screener flags 7 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.